<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="hypochondroplasia" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">hypochondroplasia</book-part-id>
      <title-group>
        <title>Hypochondroplasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Bober</surname>
            <given-names>Michael B</given-names>
          </name>
          <xref ref-type="aff" rid="hypochondroplasia.AFF1"/>
          <degrees>MD, PhD </degrees>
          <email>Michael.Bober@nemours.org</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Bellus</surname>
            <given-names>Gary A</given-names>
          </name>
          <xref ref-type="aff" rid="hypochondroplasia.AFF2"/>
          <degrees>MD, PhD</degrees>
          <email>Gary.Bellus@childrenscolorado.org</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Nikkel</surname>
            <given-names>Sarah M</given-names>
          </name>
          <xref ref-type="aff" rid="hypochondroplasia.AFF3"/>
          <degrees>MD</degrees>
          <email>snikkel@cheo.on.ca</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Tiller</surname>
            <given-names>George E</given-names>
          </name>
          <xref ref-type="aff" rid="hypochondroplasia.AFF4"/>
          <degrees>MD, PhD</degrees>
          <email>George.E.Tiller@kp.org</email>
        </contrib>
      </contrib-group>
      <aff id="hypochondroplasia.AFF1">Alfred I duPont Hospital for Children<break/>Wilmington, Delaware</aff>
      <aff id="hypochondroplasia.AFF2">Department of Pediatrics<break/>University of Colorado Denver<break/>Aurora, Colorado</aff>
      <aff id="hypochondroplasia.AFF3">Children&#x02019;s Hospital of Eastern Ontario<break/>Ottawa, Ontario</aff>
      <aff id="hypochondroplasia.AFF4">Southern California Permanente Medical Group<break/>Los Angeles, California</aff>
      <pub-history>
        <date iso-8601-date="1999-07-15" date-type="created">
          <day>15</day>
          <month>07</month>
          <year>1999</year>
        </date>
        <date iso-8601-date="2013-09-26" date-type="updated">
          <day>26</day>
          <month>09</month>
          <year>2013</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="hyper-card" document-type="chapter">Hypertrophic Cardiomyopathy Overview</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="x-hed" document-type="chapter">Hypohidrotic Ectodermal Dysplasia</related-object>
      <abstract id="hypochondroplasia.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Hypochondroplasia is a skeletal dysplasia characterized by short stature; stocky build; disproportionately short arms and legs; broad, short hands and feet; mild joint laxity; and macrocephaly. Radiologic features include shortening of long bones with mild metaphyseal flare; narrowing of the inferior lumbar interpedicular distances; short, broad femoral neck; and squared, shortened ilia. The skeletal features are very similar to those seen in achondroplasia but tend to be milder. Medical complications common to achondroplasia (e.g., spinal stenosis, tibial bowing, obstructive apnea) occur less frequently in hypochondroplasia but intellectual disability and epilepsy may be more prevalent. Children usually present as toddlers or school-age children with decreased growth velocity leading to short stature and limb disproportion. Other features also become more prominent over time. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Hypochondroplasia is diagnosed by the recognition of characteristic clinical and radiologic findings that remain controversial. The diagnosis is difficult to make in children under age three years, as skeletal disproportion tends to be mild and many of the radiographic features are subtle during infancy. DNA-based testing is possible and about 70% of affected individuals are heterozygous for a mutation in <italic toggle="yes">FGFR3</italic>. However, there is evidence that locus heterogeneity exists, implying that mutations in other as-yet unidentified genes may result in similar, if not identical, phenotypes. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management of short stature in hypochondroplasia is influenced by parental expectations and concerns; one approach is to address these concerns rather than trying to treat the child. Laminectomy relieves symptoms of spinal stenosis; about 70% of individuals experience relief of symptoms following decompression without laminectomy. Developmental milestones are followed closely during early childhood so that cognitive impairments are addressed with special educational programs. Epilepsy is treated in the standard fashion. </p>
          <p><italic toggle="yes">Surveillance</italic>: Height, weight, and head circumference should be monitored using achondroplasia-standardized growth curves. The following should be performed at routine well-child visits: neurologic examination for signs of spinal cord compression, history for evidence of sleep apnea, physical evaluation for emerging leg bowing, and monitoring for social adjustment. MRI or CT examination of the foramen magnum is indicated if there is evidence of severe hypotonia, spinal cord compression, or central sleep apnea.</p>
          <p><italic toggle="yes">Pregnancy management</italic>: Vaginal deliveries are possible, although for each pregnancy, pelvic outlet capacity should be assessed in relation to fetal head size; epidural or spinal anesthetic can be used, but a consultation with an anesthesiologist prior to delivery is recommended to assess the spinal anatomy; spinal stenosis may be aggravated during pregnancy.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Hypochondroplasia is inherited in an autosomal dominant manner. The majority of new cases result from spontaneous mutations and the unaffected parents of a child with hypochondroplasia have an extremely low risk of having another affected child. An individual with hypochondroplasia who has a partner of average stature is at a 50% risk of having a child with hypochondroplasia. If an affected individual's partner also has hypochondroplasia (or another dominant form of skeletal dysplasia), genetic counseling becomes more complicated because of (1) the risk for inheriting two dominantly inherited skeletal dysplasias, (2) the high incidence of genetic heterogeneity, and (3) the lack of medical literature addressing these circumstances. Prenatal molecular genetic testing is available if the mutation(s) in the parent(s) with hypochondroplasia have been identified; however, requests for prenatal testing for conditions such as heterozygous hypochondroplasia are not common. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="hypochondroplasia.Diagnosis">
        <title>Diagnosis</title>
        <sec id="hypochondroplasia.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The clinical and radiologic diagnostic criteria for hypochondroplasia remain controversial for several reasons, including the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>No single radiologic or clinical feature is unique to hypochondroplasia. </p>
            </list-item>
            <list-item>
              <p>The expression of many of the established diagnostic features in affected individuals is variable. </p>
            </list-item>
            <list-item>
              <p>Locus heterogeneity has been established. </p>
            </list-item>
          </list>
          <p>Genetic heterogeneity and lack of agreement on a definitive set of diagnostic criteria have made it difficult to compare data from the many studies reported in the literature [<xref ref-type="bibr" rid="hypochondroplasia.REF.ravenna.1913.157">Ravenna 1913</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.kozlowski.1965.379">Kozlowski &#x00026; Bartkowiak 1965</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.beals.1969.728">Beals 1969</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.dorst.1969.260">Dorst 1969</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.walker.1971.95">Walker et al 1971</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.kozlowski.1973.238">Kozlowski 1973</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.frydman.1974.223">Frydman et al 1974</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.newman.1975.95">Newman &#x00026; Dunbar 1975</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.specht.1975.249">Specht &#x00026; Daentl 1975</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.scott.1976.18">Scott 1976</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.glasgow.1978.868">Glasgow et al 1978</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.hall.1979.95">Hall &#x00026; Spranger 1979</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.heselson.1979.79">Heselson et al 1979</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.oberklaid.1979.140">Oberklaid et al 1979</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.wynnedavi.1981.508">Wynne-Davies et al 1981</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.maroteaux.1988.105">Maroteaux &#x00026; Falzon 1988</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.song.2012.2456">Song et al 2012</xref>]. Nevertheless, it is clear that a complete radiographic survey including skull, pelvis, AP and lateral spine, legs, arms, and hands is absolutely necessary to make a clinical diagnosis of hypochondroplasia.</p>
          <p><bold>Physical features.</bold> The diagnosis of hypochondroplasia should be considered in individuals who have the following: </p>
          <list list-type="bullet">
            <list-item>
              <p>Short stature (adult height 128-165 cm; 2-3 SD below the mean in children) </p>
            </list-item>
            <list-item>
              <p>Stocky build </p>
            </list-item>
            <list-item>
              <p>Shortening of the proximal (rhizomelia) or middle (mesomelia) segments of the extremities </p>
            </list-item>
            <list-item>
              <p>Limitation of elbow extension </p>
            </list-item>
            <list-item>
              <p>Broad, short hands and feet (brachydactyly) </p>
            </list-item>
            <list-item>
              <p>Generalized, mild joint laxity </p>
            </list-item>
            <list-item>
              <p>Large head (macrocephaly) with relatively normal facies </p>
            </list-item>
          </list>
          <p>Less common but significant clinical features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Scoliosis </p>
            </list-item>
            <list-item>
              <p>Bow legs (genu varum) (usually mild) </p>
            </list-item>
            <list-item>
              <p>Lumbar lordosis with protruding abdomen </p>
            </list-item>
            <list-item>
              <p>Mild to moderate intellectual disability</p>
            </list-item>
            <list-item>
              <p>Learning disabilities </p>
            </list-item>
            <list-item>
              <p>Adult-onset osteoarthritis </p>
            </list-item>
            <list-item>
              <p>Acanthosis nigricans</p>
            </list-item>
            <list-item>
              <p>Temporal lobe epilepsy</p>
            </list-item>
          </list>
          <p><bold>Radiologic features.</bold> The most common radiologic features of hypochondroplasia: </p>
          <list list-type="bullet">
            <list-item>
              <p>Shortening of long bones with mild metaphyseal flare (especially femora and tibiae) </p>
            </list-item>
            <list-item>
              <p>Narrowing of or failure to widen in the inferior lumbar interpedicular distances </p>
            </list-item>
            <list-item>
              <p>Mild to moderate brachydactyly </p>
            </list-item>
            <list-item>
              <p>Short, broad femoral neck </p>
            </list-item>
            <list-item>
              <p>Squared, shortened ilia </p>
            </list-item>
          </list>
          <p>Less common but significant radiologic features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Elongation of the distal fibula </p>
            </list-item>
            <list-item>
              <p>Shortening (anterior-posterior) of the lumbar pedicles </p>
            </list-item>
            <list-item>
              <p>Dorsal concavity of the lumbar vertebral bodies </p>
            </list-item>
            <list-item>
              <p>Shortening of the distal ulna </p>
            </list-item>
            <list-item>
              <p>Long ulnar styloid (seen only in adults) </p>
            </list-item>
            <list-item>
              <p>Prominence of muscle insertions on long bones </p>
            </list-item>
            <list-item>
              <p>Shallow "chevron" deformity of distal femur metaphysis </p>
            </list-item>
            <list-item>
              <p>Low articulation of sacrum on pelvis with a horizontal orientation </p>
            </list-item>
            <list-item>
              <p>Flattened acetabular roof </p>
            </list-item>
          </list>
          <p>The clinical and radiologic features above have all been described in hypochondroplasia, but a consensus opinion of which or how many of these features must be present to confirm a clinical diagnosis does not currently exist. The presence of the above listed radiologic criteria for hypochondroplasia varies significantly among affected individuals. Many of these features are not present in affected infants but develop later in life. The mild end of the hypochondroplasia phenotypic spectrum may overlap with &#x0201c;normal&#x0201d; individuals of short stature, making it difficult to establish a definitive clinical diagnosis in these individuals.</p>
        </sec>
        <sec id="hypochondroplasia.Molecular_Genetic_Test">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">FGFR3</italic> is the only gene in which mutations are known to cause hypochondroplasia and mutations throughout the gene have been described [<xref ref-type="bibr" rid="hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al 2006</xref>]. Genetic heterogeneity is suspected, as only approximately 70% of those individuals with a clinical and radiographic diagnosis of hypochondroplasia have mutations in <italic toggle="yes">FGFR3</italic>; to date, a true second locus has not been found. </p>
          <p>
            <bold>Evidence for locus heterogeneity</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Using diagnostic criteria based solely on the radiographic finding of decreased interpediculate distance between L1 and L5, <xref ref-type="bibr" rid="hypochondroplasia.REF.mullis.1991.265">Mullis et al [1991]</xref> studied 20 children with hypochondroplasia. Two RFLPs identified within introns of <italic toggle="yes">IGF1</italic> (12q23) showed a positive LOD score of 3.31 in some families with hypochondroplasia. To date, no further refinement of the genetic locus on 12q23 has been reported and no pathogenic mutations have been reported in <italic toggle="yes">IGF1</italic>.</p>
            </list-item>
            <list-item>
              <p>It is likely that, in the future, further combined molecular and clinical studies will lead to the discovery of other genetically distinct subtypes of hypochondroplasia. </p>
            </list-item>
          </list>
          <p><bold>Clinical testing</bold>
</p>
          <table-wrap id="hypochondroplasia.T.summary_of_molecular" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Hypochondroplasia</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup>
</th>
                  <th id="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method </th>
                  <th id="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Mutations Detected&#x000a0;<sup>2</sup>
</th>
                  <th id="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_1" align="left" valign="middle" rowspan="4" colspan="1">
                    <italic toggle="yes">FGFR3</italic>
                  </td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_2" align="left" valign="middle" rowspan="2" colspan="1">Targeted mutation analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;A</xref>&#x000a0;<sup>5</sup>
</td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">70%&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"><xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;G</xref>&#x000a0;<sup>5</sup></td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">30%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Sequence variants (including <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;A</xref> and <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;G</xref></td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>9</sup></td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Exonic or whole-gene deletion/duplication </td>
                  <td headers="hd_b_hypochondroplasia.T.summary_of_molecular_1_1_1_4" align="left" valign="middle" rowspan="1" colspan="1">Unknown, none reported&#x000a0;<sup>10</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="hypochondroplasia.TF.1">
                <p>1. See <related-object source-id="gene" document-id="hypochondroplasia" object-id="hypochondroplasia.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.1">
                <p>2. See <xref ref-type="sec" rid="hypochondroplasia.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
              </fn>
              <fn id="hypochondroplasia.TF.1.2">
                <p>3. The ability of the test method used to detect a mutation that is present in the indicated gene</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.3">
                <p>4. Mutation panels may vary by laboratory.</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.4">
                <p>5.&#x000a0;The two most common mutations, detection frequency based on testing of 188 individuals with hypochondroplasia See also <xref ref-type="sec" rid="hypochondroplasia.Testing_Strategy">Testing Strategy</xref>.</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.5">
                <p>6. In studies in which a diagnosis was established by physical and radiologic criteria, 70% (180/258) of probands with hypochondroplasia were found to be heterozygous for one mutation resulting in c.1620C&#x0003e;A [<xref ref-type="bibr" rid="hypochondroplasia.REF.prinos.1995.2097">Prinos et al 1995</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1996.182">Bellus et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.rousseau.1996.749">Rousseau et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.fofanova.1998.791">Fofanova et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.prinster.1998.109">Prinster et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.ramaswami.1998.99">Ramaswami et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al 2006</xref>]. </p>
              </fn>
              <fn id="hypochondroplasia.TF.1.6">
                <p>7. Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.7">
                <p>8. <xref ref-type="bibr" rid="hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al [2006]</xref> reported 54 <italic toggle="yes">FGFR3</italic> mutations detected by sequencing all coding regions in 74 probands with hypochondroplasia (47 [87%] were <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;A</xref> ), whereas <xref ref-type="bibr" rid="hypochondroplasia.REF.song.2012.2456">Song et al [2012]</xref>, using broader diagnostic criteria for hypochondroplasia to diagnose 58 individuals, found 19 <italic toggle="yes">FGFR3</italic> mutations (10 [58%] were <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;A</xref>).</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.8">
                <p>9. Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="hypochondroplasia.TF.1.9">
                <p>10. No deletions or duplications involving&#x000a0;<italic toggle="yes">FGFR3</italic> have been reported to cause hypochondroplasia.&#x000a0;</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="hypochondroplasia.Testing_Strategy">
          <title>Testing Strategy </title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <p><bold>Single gene testing.</bold> One strategy for molecular diagnosis of a proband suspected of having hypochondroplasia is sequence analysis (or targeted mutations) of <italic toggle="yes">FGFR3</italic>. </p>
          <list list-type="bullet">
            <list-item>
              <p>Targeted mutation analysis for the two common mutations should be pursued first.</p>
            </list-item>
            <list-item>
              <p>Sequence analysis can be performed when the suspicion of hypochondroplasia based on clinical and radiographic grounds is high and targeted mutation analysis for the two common mutations is normal. As mutations have been reported in almost all domains of the protein, analysis should include sequencing of all coding regions. To date, only missense mutations have been described.</p>
            </list-item>
          </list>
          <p><bold>Multi-gene panel.</bold> Another strategy for molecular diagnosis of a proband suspected of having hypochondroplasia is use of a multi-gene panel.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutation in the family.</p>
        </sec>
      </sec>
      <sec id="hypochondroplasia.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="hypochondroplasia.Natural_History">
          <title>Clinical Description</title>
          <p><bold>Growth.</bold> The most common presenting feature of children with hypochondroplasia is short stature with disproportionate limbs. Birth weight and length are often within the normal range and the disproportion in limb-to-trunk length is often mild and easily overlooked during infancy. Typically, these children present as toddlers or school-age children to pediatricians or pediatric endocrinologists with decreased growth velocity leading to short stature. Some investigators have reported the absence of a pubertal growth spurt [<xref ref-type="bibr" rid="hypochondroplasia.REF.appan.1990.796">Appan et al 1990</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bridges.1991.56">Bridges et al 1991</xref>]. Overall height is usually two to three standard deviations below the mean during childhood, and adult heights range from 138 to 165 cm (54" to 65") for men and 128 to 151 cm (50" to 59") for women [<xref ref-type="bibr" rid="hypochondroplasia.REF.maroteaux.1988.105">Maroteaux &#x00026; Falzon 1988</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.appan.1990.796">Appan et al 1990</xref>].</p>
          <p>With age, limb disproportion usually becomes more prominent in the legs than the arms. Both rhizomelic [<xref ref-type="bibr" rid="hypochondroplasia.REF.frydman.1974.223">Frydman et al 1974</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.specht.1975.249">Specht &#x00026; Daentl 1975</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.maroteaux.1988.105">Maroteaux &#x00026; Falzon 1988</xref>] and mesomelic [<xref ref-type="bibr" rid="hypochondroplasia.REF.beals.1969.728">Beals 1969</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.walker.1971.95">Walker et al 1971</xref>] shortening have been reported, although others have reported the predominance of neither [<xref ref-type="bibr" rid="hypochondroplasia.REF.hall.1979.95">Hall &#x00026; Spranger 1979</xref>]. The hands are relatively short but do not exhibit the "trident" appearance that is typical in achondroplasia. Facial features are usually normal and the classic facial features of achondroplasia (e.g., midfaceretrusion, frontal bossing) are not generally seen. Head size may be large without significant disproportion. </p>
          <p><bold>Orthopedics.</bold> When children begin to walk, exaggerated lumbar lordosis and mild genu varum (bow legs) are often noted. The genu varum is usually transient and rarely requires surgical intervention. Young children and adults often have a thick, muscular appearance and may be described as "stocky." Joint pain, back pain, and other symptoms of osteoarthritis may occur later in life. Multiple suture craniosynostosis has been reported in one case [<xref ref-type="bibr" rid="hypochondroplasia.REF.angle.1998.417">Angle et al 1998</xref>].</p>
          <p><bold>Cognitive development.</bold> The incidence of intellectual disability is thought to be higher in hypochondroplasia than in achondroplasia or the general population. This observation has been controversial and several studies have reported conflicting results [<xref ref-type="bibr" rid="hypochondroplasia.REF.beals.1969.728">Beals 1969</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.walker.1971.95">Walker et al 1971</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.frydman.1974.223">Frydman et al 1974</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.specht.1975.249">Specht &#x00026; Daentl 1975</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.hall.1979.95">Hall &#x00026; Spranger 1979</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.wynnedavi.1991.644">Wynne-Davies &#x00026; Patton 1991</xref>]. It is unclear whether these discrepancies result from sampling bias, genetic heterogeneity, or both; more studies with rigorous diagnostic criteria are required to resolve this issue. Preliminary studies [Bellus &#x00026; Francomano, unpublished results] suggest that individuals with the <italic toggle="yes">FGFR3</italic> p.Asn540Lys substitution may have an increased incidence of mild-to-moderate intellectual disability or learning disabilities. Eight of 13 Finnish individuals with the <italic toggle="yes">FGFR3</italic> p.Asn540Lys substitution had neurocognitive difficulties [<xref ref-type="bibr" rid="hypochondroplasia.REF.linnanki.2012.3119">Linnankivi et al 2012</xref>] (see <bold>Neurology</bold>).</p>
          <p><bold>Endocrinology.</bold> Acanthosis nigricans is observed occasionally in children and adults with hypochondroplasia [<xref ref-type="bibr" rid="hypochondroplasia.REF.leroy.2007.3144">Leroy et al 2007</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.castrofei.2008.243">Castro-Feijoo et al 2008</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.alatzogl.2009.3959">Alatzoglou et al 2009</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.berk.2010.664">Berk et al 2010</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.blomberg.2010.297">Blomberg et al 2010</xref>] and appears to be more prevalent in individuals with specific <italic toggle="yes">FGFR3</italic> mutations (i.e., p.Lys650Gln and p.Lys650Thr). The severity of acanthosis nigricans in individuals reported with these mutations is much milder than that observed in SADDAN syndrome (<italic toggle="yes">FGFR3</italic> mutation p.Lys650Met). While increased insulin resistance has been reported in one individual with acanthosis nigricans and hypochondroplasia due to a p.Lys650Gln mutation [<xref ref-type="bibr" rid="hypochondroplasia.REF.blomberg.2010.297">Blomberg et al 2010</xref>], no evidence of insulin resistance was found in an individual with acanthosis nigricans and hypochondroplasia due to a p.Asn540Lys mutation [<xref ref-type="bibr" rid="hypochondroplasia.REF.alatzogl.2009.3959">Alatzoglou et al 2009</xref>]. Insulin resistance is also not found in SADDAN syndrome [<xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1999.53">Bellus et al 1999</xref>].</p>
          <p><bold>Neurology.</bold> Symptoms of spinal stenosis are seen in some adults with hypochondroplasia, but occur much less frequently and tend to be milder than those seen in achondroplasia [<xref ref-type="bibr" rid="hypochondroplasia.REF.wynnedavi.1981.508">Wynne-Davies et al 1981</xref>]. Unlike achondroplasia, motor milestones are usually not significantly delayed and symptoms resulting from spinal cord compression (e.g., apnea, neuropathy) are less common [<xref ref-type="bibr" rid="hypochondroplasia.REF.wynnedavi.1981.508">Wynne-Davies et al 1981</xref>].</p>
          <p><xref ref-type="bibr" rid="hypochondroplasia.REF.hulse.2012.1">Hulse et al [2012]</xref> described a male with hypochondroplasia (p.Asn540Lys) who developed seizures in the neonatal period. EEGs revealed abnormalities in the left temporal lobe region, and brain MRI revealed abnormal orientation of the hippocampal heads. Reference was made to four other reported cases of medial temporal lobe epilepsy related to hypochondroplasia.</p>
          <p><xref ref-type="bibr" rid="hypochondroplasia.REF.linnanki.2012.3119">Linnankivi et al [2012]</xref> assessed neurologic and neuroimaging aspects of 13 Finnish individuals with hypochondroplasia with a confirmed <italic toggle="yes">FGFR3</italic> p.Asn540Lys substitution. Eight affected individuals had neurocognitive difficulties, ranging from specific learning disorder (2/13) to mild intellectual disability (5/13) or global developmental delay (1/13). Six of 13 affected individuals had a history of epilepsy. Of eight individuals who underwent head MRI, all had temporal lobe dysgenesis, six had peritrigonal white matter reduction, and four had abnormally shaped lateral ventricles. </p>
        </sec>
        <sec id="hypochondroplasia.GenotypePhenotype_Corr">
          <title>Genotype-Phenotype Correlations</title>
          <p>Other than <xref ref-type="table" rid="hypochondroplasia.T.summary_of_molecular">p.Asn540Lys</xref>, most mutations have not been reported in high enough frequency to make any generalizations about specific genotype/phenotype manifestations.</p>
          <list list-type="bullet">
            <list-item>
              <p>As one would expect, no difference exists in phenotype between the <italic toggle="yes">FGFR3</italic>
<xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;A</xref> and <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.1620C&#x0003e;G</xref> mutations, as they result in identical mutant proteins, p.Asn540Lys. In general, it appears that the phenotypes of individuals diagnosed with hypochondroplasia who have <italic toggle="yes">FGFR3</italic> mutations c.1620C&#x0003e;A or c.1620C&#x0003e;G have more severe manifestations than those with hypochrondroplasia who do not have these mutations [<xref ref-type="bibr" rid="hypochondroplasia.REF.rousseau.1996.749">Rousseau et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.prinster.1998.109">Prinster et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.ramaswami.1998.99">Ramaswami et al 1998</xref>]. More recently, both <xref ref-type="bibr" rid="hypochondroplasia.REF.heuertz.2006.1240">Heuertz et al [2006]</xref> and <xref ref-type="bibr" rid="hypochondroplasia.REF.song.2012.2456">Song et al [2012]</xref> reported that a p.Tyr278Cys (<xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">c.829A&#x0003e;G</xref>) mutation resulted in a phenotype that resembled achondroplasia in the newborn period. There is still no consensus as to which specific clinical features distinguish hypochondroplasia due to <italic toggle="yes">FGFR3</italic> p.Asn540Lys from hypochondroplasia caused by other <italic toggle="yes">FGFR3</italic> mutations or from non- <italic toggle="yes">FGFR3</italic>-related hypochondroplasia. </p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="hypochondroplasia.REF.fano.2005.782">Fano et al [2005]</xref> reported that affected individuals with a head circumference greater than 1.86 standard deviations had a greater likelihood of possessing the p.Asn540Lys mutation.</p>
            </list-item>
            <list-item>
              <p>Individuals with p.Lys650Gln or p.Lys650Thr have a higher likelihood of developing acanthosis nigricans (see <xref ref-type="sec" rid="hypochondroplasia.Natural_History">Clinical Description</xref>, <bold>Endocrinology</bold>). </p>
            </list-item>
            <list-item>
              <p>Mutations resulting in <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">p.Lys650Asn</xref> and <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">p.Lys650Gln</xref> are associated with a slightly milder skeletal phenotype than mutations resulting in p.Asn540Lys. <xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.2000.1411">Bellus et al [2000]</xref> reported six individuals with p.Lys650Asn or p.Lys650Gly who had a significantly lower average height deficit than 36 individuals with p.Asn540Lys. In addition, the L1:L4 interpediculate distance and fibula/tibia length ratios were closer to normal. </p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="hypochondroplasia.REF.mortier.2000.220">Mortier et al [2000]</xref> and <xref ref-type="bibr" rid="hypochondroplasia.REF.thauvinrob.2003.81">Thauvin-Robinet et al [2003]</xref> reported on families with p.Asn540Lys. The phenotype in both families was relatively mild, with heights overlapping the lower end of the normal range for age, mild disproportion of the limbs, and macrocephaly. </p>
            </list-item>
          </list>
          <p>Somatic mosaicism has not been reported in hypochondroplasia. </p>
        </sec>
        <sec id="hypochondroplasia.Penetrance">
          <title>Penetrance</title>
          <p>Because of evidence that the height range in hypochondroplasia may overlap that of the normal population, individuals with hypochondroplasia may not be recognized as having a skeletal dysplasia unless an astute physician recognizes their disproportionate short stature. However, there have been no reports of individuals with an <italic toggle="yes">FGFR3</italic> mutation without demonstrable radiographic changes compatible with hypochondroplasia or one of the other phenotypes known to be associated with mutations in this gene (see <xref ref-type="sec" rid="hypochondroplasia.Genetically_Related_Al">Genetically Related Disorders</xref>).</p>
        </sec>
        <sec id="hypochondroplasia.Anticipation">
          <title>Anticipation </title>
          <p>Genetic anticipation is not known to occur in hypochondroplasia. </p>
        </sec>
        <sec id="hypochondroplasia.Prevalence">
          <title>Prevalence</title>
          <p>No studies attempting to determine the prevalence of <italic toggle="yes">FGFR3</italic> and/or non- <italic toggle="yes">FGFR3</italic> hypochondroplasia have been published. Ascertainment of cases is problematic as it is thought that many affected individuals present with no symptoms other than short stature and do not seek medical intervention. However, it is generally agreed that hypochondroplasia is a relatively common skeletal dysplasia that may approach the prevalence of achondroplasia (i.e., one in 15,000 - 40,000 live births). In addition, simplex cases (affected individuals with no family history of hypochondroplasia) have been associated with advanced paternal age. Simplex cases of hypochondroplasia caused by the <italic toggle="yes">FGFR3</italic> p.Asn540Lys mutation are probably not as common as simplex cases of achondroplasia, given the fact that a transition at a CpG dinucleotide is the most common cause of the <related-object link-type="booklink" source-id="gene" document-id="achondroplasia" document-type="chapter">achondroplasia</related-object>-causing p.Gly380Arg change, while both mutations leading to <xref ref-type="table" rid="hypochondroplasia.T.fgfr3_pathogenic_var">p.Asn540Lys</xref> result from transversions not associated with CpG dinucleotides.</p>
        </sec>
      </sec>
      <sec id="hypochondroplasia.Genetically_Related_Al">
        <title>Genetically Related (Allelic) Disorders </title>
        <p>The other phenotypes associated with mutations in <italic toggle="yes">FGFR3</italic>: </p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="td" document-type="chapter">Thanatophoric dysplasia</related-object> (TD) is a short-limb dwarfism syndrome that is usually lethal in the perinatal period. TD is divided into type I, characterized by micromelia with bowed femurs and, uncommonly, the presence of cloverleaf skull deformity (kleeblattschaedel) of varying severity; and type II, characterized by micromelia with straight femurs and uniform presence of moderate-to-severe cloverleaf skull deformity. Other features common to type I and type II include: short ribs, narrow thorax, macrocephaly, distinctive facial features, brachydactyly, hypotonia, and redundant skin folds along the limbs. Most affected infants die of respiratory insufficiency shortly after birth. Rare long-term survivors have been reported. </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="achondroplasia" document-type="chapter">Achondroplasia</related-object>. It should be noted that mild cases of achondroplasia caused by <italic toggle="yes">FGFR3</italic> p.Gly380Arg substitutions and severe cases of hypochondroplasia caused by <italic toggle="yes">FGFR3</italic> p.Asn540Lys may have very similar clinical presentations and are thus easily confused. Therefore, it is important to test for both <italic toggle="yes">FGFR3</italic> mutations resulting in p.Asn540Lys and both mutations resulting in p.Gly380Arg (c.1138G&#x0003e;A and c.1138G&#x0003e;C) when molecular testing is requested for hypochondroplasia. </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="craniosynostosis" document-type="chapter"><italic toggle="yes">FGFR</italic>-related craniosynostosis</related-object>. The eight disorders comprising the <italic toggle="yes">FGFR</italic>-related craniosynostosis spectrum are Pfeiffer syndrome, Apert syndrome, Crouzon syndrome, Beare-Stevenson syndrome, <italic toggle="yes">FGFR2</italic>-related isolated coronal synostosis, Jackson-Weiss syndrome, Crouzon syndrome with acanthosis nigricans (AN), and Muenke syndrome (isolated coronal synostosis caused by the p.Pro250Arg mutation in <italic toggle="yes">FGFR3</italic>). Muenke syndrome and <italic toggle="yes">FGFR2</italic>-related isolated coronal synostosis are characterized only by uni- or bicoronal craniosynostosis; the remainder are characterized by bicoronal craniosynostosis or cloverleaf skull, distinctive facial features, and variable hand and foot findings. </p>
          </list-item>
          <list-item>
            <p>SADDAN (<italic toggle="yes">s</italic>evere <italic toggle="yes">a</italic>chondroplasia with <italic toggle="yes">d</italic>evelopmental <italic toggle="yes">d</italic>elay and <italic toggle="yes">a</italic>canthosis <italic toggle="yes">n</italic>igricans) is caused by <italic toggle="yes">FGFR3</italic> mutation p.Lys650Met [<xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1999.53">Bellus et al 1999</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.tavormina.1999.722">Tavormina et al 1999</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="hypochondroplasia.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Numerous forms of skeletal dysplasia with disproportionate limbs are recognized and are characterized by clinical and radiologic features that distinguish them from hypochondroplasia and achondroplasia. Many of these disorders are quite rare. The diagnosis of hypochondroplasia is seldom made at birth unless a prior family history exists. Most affected individuals present with short stature as toddlers or young school-age children. Inappropriate diagnoses of hypochondroplasia are often made because the disorder is considered to be relatively common and the radiologic features are variable and may be subtle. The following conditions may be confused with hypochondroplasia:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mild <related-object link-type="booklink" source-id="gene" document-id="achondroplasia" document-type="chapter">achondroplasia</related-object>
</p>
          </list-item>
          <list-item>
            <p>Mild forms of metaphyseal chondrodysplasias </p>
          </list-item>
          <list-item>
            <p>Mild forms of mesomelic dwarfism </p>
          </list-item>
          <list-item>
            <p>Mild forms of spondylo-epiphyseal-metaphyseal dysplasias </p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="lwd" document-type="chapter">Leri-Weill dyschondrosteosis</related-object>
</p>
          </list-item>
          <list-item>
            <p>Pseudohypoparathyroidism and pseudopseudohypoparathyroidism </p>
          </list-item>
          <list-item>
            <p>Short stature caused by disturbances in the growth hormone axis </p>
          </list-item>
          <list-item>
            <p>Constitutive short stature </p>
          </list-item>
        </list>
        <p><bold>Hypochondroplasia-achondroplasia complex</bold>
<italic toggle="yes">(FGFR3</italic> p.[Asn540Lys];[Gly380Arg]) has been reported [<xref ref-type="bibr" rid="hypochondroplasia.REF.mckusick.1973.11">McKusick et al 1973</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.sommer.1987.949">Sommer et al 1987</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1995.357">Bellus et al 1995</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.huggins.1999.396">Huggins et al 1999</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.flynn.2003.193">Flynn &#x00026; Pauli 2003</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bober.2012.2336">Bober et al 2012</xref>]. The skeletal phenotype is more severe than typically found in achondroplasia, but unlike homozygous achondroplasia, is not uniformly lethal. Life span however, may be decreased. </p>
        <p><bold>Hypochondroplasia-<italic toggle="yes">SHOX</italic> deletion.</bold>
<xref ref-type="bibr" rid="hypochondroplasia.REF.ross.2003.61">Ross et al [2003]</xref> described the phenotype in one child with compound heterozygosity for Leri-Weil dyschondrosteosis and hypochondroplasia. This child inherited both a <italic toggle="yes">SHOX</italic> deletion and the p.Asn540Lys <italic toggle="yes">FGFR3</italic> mutation, and had severe short stature with both rhizomelic and mesomelic shortening of the limbs. </p>
      </sec>
      <sec id="hypochondroplasia.Management">
        <title>Management</title>
        <sec id="hypochondroplasia.Evaluations_Following">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>Evaluation of children with hypochondroplasia usually does not differ significantly from the evaluation of children with normal stature except for genetic counseling issues and dealing with parental concerns about short stature. However, because the phenotype of <italic toggle="yes">FGFR3</italic> hypochondroplasia may overlap with that of achondroplasia, recommendations for the management of achondroplasia as outlined by the American Academy of Pediatrics Committee on Genetics [<xref ref-type="bibr" rid="hypochondroplasia.REF.trotter.2005.771">Trotter et al 2005</xref>] should be considered in children with hypochondroplasia who exhibit more severe phenotypic features. These recommendations include but are not limited to the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
            <list-item>
              <p>Measurement of height, weight, and head circumference and plotting on achondroplasia-standardized growth curves </p>
            </list-item>
            <list-item>
              <p>Neurologic examination for signs of spinal cord compression, with referral to a pediatric neurologist or neurosurgeon if needed </p>
            </list-item>
            <list-item>
              <p>Screening developmental assessment </p>
            </list-item>
            <list-item>
              <p>History for evidence of sleep apnea, with formal sleep study if suggestive </p>
            </list-item>
            <list-item>
              <p>MRI or CT examination of the foramen magnum if clinical findings of severe hypotonia, spinal cord compression, or central sleep apnea as demonstrated through a sleep study are present</p>
            </list-item>
            <list-item>
              <p>Evaluation for thoracic or lumbar gibbus in the presence of truncal weakness </p>
            </list-item>
            <list-item>
              <p>Examination for leg bowing, with orthopedic referral if bowing interferes with walking </p>
            </list-item>
            <list-item>
              <p>Speech evaluation at diagnosis or by age two years </p>
            </list-item>
            <list-item>
              <p>Observation for symptoms suggestive of epilepsy, with referral to a pediatric neurologist when indicated </p>
            </list-item>
          </list>
        </sec>
        <sec id="hypochondroplasia.Treatment_of_Manifesta">
          <title>Treatment of Manifestations</title>
          <p>Management of short stature is influenced by parental expectations and concerns. Final adult height in hypochondroplasia is considerably greater than that achieved in achondroplasia and therefore, functional limitations in society (e.g., operating an elevator, driving a car, using an automatic teller machine) are generally less severe or not an issue. One reasonable approach is to address the parents' expectations and prejudices regarding the height of their child rather than attempting to treat the child. </p>
          <p>Developmental intervention and special educational input are appropriate, as indicated by deficiencies. </p>
          <p>The usual neurosurgical approach to spinal stenosis is laminectomy. <xref ref-type="bibr" rid="hypochondroplasia.REF.thomeer.2002.292">Thomeer &#x00026; van Dijk [2002]</xref> determined that about 70% of symptomatic individuals with <related-object link-type="booklink" source-id="gene" document-id="achondroplasia" document-type="chapter">achondroplasia</related-object> experienced total relief of symptoms following decompression without laminectomy. The L2-3 level most commonly required decompression. </p>
          <p>Making the family aware of support groups, such as the Little People of America Inc. (LPA), can result in assistance with adaptation of the affected individual and the family to short stature through peer support, personal example, and social awareness programs. The LPA offers information on employment, education, disability rights, adoption of children of short stature, medical issues, suitable clothing, adaptive devices, and parenting through local meetings, workshops, seminars, and a national newsletter. </p>
          <p>Seizure disorders should be treated in the standard manner. </p>
        </sec>
        <sec id="hypochondroplasia.Prevention_of_Secondar">
          <title>Prevention of Secondary Complications</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Standard management of frequent middle ear infections </p>
            </list-item>
            <list-item>
              <p>Consideration of surgery if neurologic status is affected by spinal cord compression </p>
            </list-item>
          </list>
        </sec>
        <sec id="hypochondroplasia.Surveillance">
          <title>Surveillance</title>
          <p>Height, weight, and head circumference should be monitored using achondroplasia-standardized growth curves. </p>
          <p>Because an increased prevalence of mild-to-moderate intellectual disability and/or learning disabilities in children with hypochondroplasia appears likely, developmental milestones should be followed closely during early childhood and a timely referral to an appropriate professional made if there are any indications of learning difficulties during school-age years. </p>
          <p>Neurologic examination for signs of spinal cord compression should be performed at routine well-child visits, with referral to a pediatric neurologist if needed. </p>
          <p>History for evidence of sleep apnea should be taken at routine visits, with formal sleep study obtained when indicated. </p>
          <p>MRI or CT examination of the foramen magnum is indicated if there is evidence of severe hypotonia, spinal cord compression or central sleep apnea. </p>
          <p>Affected individuals should be evaluated for emerging leg bowing at routine visits, with orthopedic referral if bowing interferes with walking. </p>
          <p>Social adjustment should be monitored. </p>
        </sec>
        <sec id="hypochondroplasia.Evaluation_of_Relative">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="hypochondroplasia.Related_Genetic_Counse">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
          <p>
            <bold>Pregnancy Management</bold>
          </p>
          <p>There is a paucity of literature regarding pregnancy management in women with skeletal dysplasias. However, a number of women with hypochondroplasia have had unremarkable pregnancies and deliveries. </p>
          <list list-type="bullet">
            <list-item>
              <p>In comparison to women who have achondroplasia, vaginal deliveries are possible, although for each pregnancy, pelvic outlet capacity should be assessed in relation to fetal head size. </p>
            </list-item>
            <list-item>
              <p>Epidural or spinal anesthetic can be utilized, but a consultation with an anesthesiologist prior to delivery is recommended to assess the spinal anatomy. </p>
            </list-item>
            <list-item>
              <p>If present, spinal stenosis may be aggravated during pregnancy due to the normal physiologic changes to the shape of the spine that occur as gestation progresses.</p>
            </list-item>
          </list>
        </sec>
        <sec id="hypochondroplasia.Therapies_Under_Invest">
          <title>Therapies Under Investigation</title>
          <p><bold>Growth hormone therapy.</bold> Trials of growth hormone therapy in hypochondroplasia have shown mixed results. These differences in individual responses published prior to gene discovery in 1995 [<xref ref-type="bibr" rid="hypochondroplasia.REF.appan.1990.796">Appan et al 1990</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bridges.1991.56">Bridges et al 1991</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.mullis.1991.265">Mullis et al 1991</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bridges.1994.231">Bridges &#x00026; Brook 1994</xref>] may have resulted from genetic heterogeneity and indicate a need for stratification of affected individuals with regard to genetic etiology (e.g., those with <italic toggle="yes">FGFR3</italic> mutations and those without). <xref ref-type="bibr" rid="hypochondroplasia.REF.meyer.2003.177">Meyer et al [2003]</xref> emphasized the importance of considering pubertal development in assessing the response to growth hormone stimulation testing. <xref ref-type="bibr" rid="hypochondroplasia.REF.tanaka.2003.69">Tanaka et al [2003]</xref> reported data suggesting that children with hypochondroplasia may have a greater response to growth hormone therapy than children with achondroplasia. </p>
          <p><xref ref-type="bibr" rid="hypochondroplasia.REF.pinto.2012.193">Pinto et al [2012]</xref> treated 19 children with hypochondroplasia (11/19 with confirmed <italic toggle="yes">FGFR3</italic> mutations, mean age 9.0+/-3.0 years) with human recombinant growth hormone over a three-year period. Their mean height increased 1.32+/-1.05 standard deviation score (SDS) compared to a historical cohort of 40 untreated individuals with hypochondroplasia. <xref ref-type="bibr" rid="hypochondroplasia.REF.rothenbuh.2012.849">Rothenbuhler et al [2012]</xref> treated six children with hypochondroplasia (confirmed <italic toggle="yes">FGFR3</italic> p.Asn540Lys substitution, mean age 2.6+/-0.7 years) with human recombinant growth hormone over a six-year period. Their mean height SDS increased by 1.9 during the study period, and trunk/leg disproportion was improved. Since data about final adult height in growth hormone-treated individuals with hypochondroplasia are not available, the ultimate success of this approach remains uncertain. Growth hormone therapy should still be considered experimental and controversial in this condition.</p>
          <p><bold>Surgical limb lengthening procedures</bold> have been used to treat achondroplasia and hypochondroplasia for more than 15 years. Although the complication rate was high initially, outcomes have steadily improved and significant increases in overall height have been reported [<xref ref-type="bibr" rid="hypochondroplasia.REF.yasui.1997.298">Yasui et al 1997</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.lie.2009.280">Lie &#x00026; Chow 2009</xref>]. Nevertheless, the procedure is very invasive and entails considerable disability and discomfort over a long period of time. While some advocate performing the procedure during childhood, many pediatricians, geneticists, and ethicists advocate postponement until adolescence, when the affected individual is able to make an informed decision. Surgical limb lengthening is controversial, but is achieving greater acceptance with fewer complications as larger numbers of operations have been performed.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="hypochondroplasia.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="hypochondroplasia.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Hypochondroplasia is inherited in an autosomal dominant manner. </p>
        </sec>
        <sec id="hypochondroplasia.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of individuals with hypochondroplasia have parents of average stature and represent simplex occurrences caused by a <italic toggle="yes">de novo</italic> mutation; however, in some instances, one or both parents have hypochondroplasia. </p>
            </list-item>
            <list-item>
              <p>There appears to be a paternal age effect in some simplex occurrences of hypochondroplasia [<xref ref-type="bibr" rid="hypochondroplasia.REF.walker.1971.95">Walker et al 1971</xref>]. It is likely that <italic toggle="yes">de novo</italic> mutations occur on the paternally derived chromosome during spermatogenesis, as has been shown in achondroplasia [<xref ref-type="bibr" rid="hypochondroplasia.REF.wilkin.1998.711">Wilkin et al 1998</xref>] and Apert syndrome [<xref ref-type="bibr" rid="hypochondroplasia.REF.moloney.1996.48">Moloney et al 1996</xref>].</p>
            </list-item>
            <list-item>
              <p>Because the skeletal features of hypochondroplasia are milder than those of achondroplasia and the incidence of disabilities is lower, the reproductive fitness of individuals with hypochondroplasia is most likely greater than that of individuals with achondroplasia. It is likely that the number of families with multiple affected members is higher for hypochondroplasia than for achondroplasia, and that the percentage of cases of hypochondroplasia attributable to <italic toggle="yes">de novo</italic> mutations is less than the 80% figure stated for achondroplasia. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs of the proband depends on the genetic status of the parents. </p>
            </list-item>
            <list-item>
              <p>If one parent is affected, the risk is 50%. </p>
            </list-item>
            <list-item>
              <p>If both parents have hypochondroplasia or one has hypochondroplasia and the other has a different autosomal dominant skeletal dysplasia, the risk to sibs is more complex (see <bold>Offspring of a proband</bold>). </p>
            </list-item>
            <list-item>
              <p>Germline mosaicism has not been reported for hypochondroplasia and therefore the risk that the sibs of an affected individual born to parents of normal stature would have hypochondroplasia appears to be extremely low (&#x0003c;0.01%). </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>An individual with hypochondroplasia who has a reproductive partner of average stature is at a 50% risk of having a child with hypochondroplasia. </p>
            </list-item>
            <list-item>
              <p>When the proband and the proband's reproductive partner are affected with the same or a different skeletal dysplasia, genetic counseling is more complicated. In general, if both members of a couple have a dominantly inherited skeletal dysplasia, each child has a 25% chance of having normal stature, a 25% chance of having the same skeletal dysplasia as the father, a 25% chance of having the same skeletal dysplasia as the mother, and a 25% chance of inheriting a disease-causing mutation from both parents and being at risk for a potentially poor pregnancy outcome. </p>
              <list list-type="bullet">
                <list-item>
                  <p>Individuals who are compound heterozygotes for <italic toggle="yes">FGFR3</italic> p.[Asn540Lys];[Gly380Arg]), the mutations that cause hypochondroplasia and achondroplasia, respectively or individuals in whom the hypochondroplasia results from <italic toggle="yes">FGFR3</italic> p.Asn540Lys have a severe skeletal phenotype with the potential for serious disability [<xref ref-type="bibr" rid="hypochondroplasia.REF.mckusick.1973.11">McKusick et al 1973</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.sommer.1987.949">Sommer et al 1987</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.huggins.1999.396">Huggins et al 1999</xref>].</p>
                </list-item>
                <list-item>
                  <p>Poor outcomes have been reported for individuals who are compound heterozygotes for achondroplasia and spondyloepiphyseal dysplasia congenita [<xref ref-type="bibr" rid="hypochondroplasia.REF.young.1992.831">Young et al 1992</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.gunthard.1995.35">Gunthard et al 1995</xref>] or achondroplasia and pseudoachondroplasia [<xref ref-type="bibr" rid="hypochondroplasia.REF.langer.1993.772">Langer et al 1993</xref>]. </p>
                </list-item>
                <list-item>
                  <p>Compound heterozygotes for either achondroplasia and dyschondrosteosis or hypochondroplasia and dyschondrosteosis have phenotypes that do not appear to be more severe than that of either parent [<xref ref-type="bibr" rid="hypochondroplasia.REF.ross.2003.61">Ross et al 2003</xref>]. </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Genetic counseling of couples both of whom have hypochondroplasia is complicated by (1) genetic heterogeneity and (2) lack of information about the phenotypes and prognosis for offspring who inherit a disease-causing mutation from both parents. No reports address the following phenotypes </p>
              <list list-type="bullet">
                <list-item>
                  <p>Individuals with hypochondroplasia who are homozygous for <italic toggle="yes">FGFR3</italic> mutations or homozygous for non- <italic toggle="yes">FGFR3</italic> mutations </p>
                </list-item>
                <list-item>
                  <p>Individuals who are compound heterozygotes for an <italic toggle="yes">FGFR3</italic> mutation and a non- <italic toggle="yes">FGFR3</italic> mutation </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Similarly, the following phenotypes have not been described:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Individuals who are compound heterozygotes for a non- <italic toggle="yes">FGFR3</italic> mutation causing hypochondroplasia and an <italic toggle="yes">FGFR3</italic> mutation causing achondroplasia </p>
                </list-item>
                <list-item>
                  <p>Individuals who are compound heterozygotes for hypochondroplasia (as a result of either an <italic toggle="yes">FGFR3</italic> mutation or a mutation in a different gene) and another dominantly inherited skeletal dysplasia (except individuals who are compound heterozygotes for <italic toggle="yes">FGFR3</italic> mutations causing hypochondroplasia and achondroplasia. See above: Individuals who are compound heterozygotes for <italic toggle="yes">FGFR3</italic>). </p>
                </list-item>
                <list-item>
                  <p>Therefore, it is not possible to provide information about prognosis for all at-risk offspring.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk. </p>
        </sec>
        <sec id="hypochondroplasia.Related_Genetic_Counse">
          <title>Related Genetic Counseling Issues</title>
          <p>Genetic counseling for hypochondroplasia presents dilemmas relating to ethical and genetic issues. Hypochondroplasia is considered a mild disorder in which the chief physical disability is generally short stature. Many affected individuals do not think of themselves as disabled. However, some parents may consider short stature a significant physical, emotional, and/or social disability. Furthermore, a child with hypochondroplasia may have intellectual disability or a learning disability. An additional issue is genetic heterogeneity (i.e., mutations in more than one gene causing hypochondroplasia), which may result in an inability to predict phenotype or prognosis and/or make diagnosis difficult.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has the disease-causing mutation or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. </p>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="hypochondroplasia.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>
            <bold>High-risk pregnancy</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Molecular genetic testing.</bold> A high-risk pregnancy is one in which one parent has hypochondroplasia and the other parent is of normal stature, has hypochondroplasia, or has another dominantly inherited skeletal dysplasia. Prenatal diagnosis for high-risk pregnancies is possible by analysis of DNA extracted from fetal cells obtained by amniocentesis usually performed at about 15 to 18 weeks' gestation or chorionic villus sampling (CVS) at about ten to 12 weeks' gestation. The mutation in the parent with hypochondroplasia must be identified before prenatal testing can be performed. Similarly, if the other parent has a dominantly inherited skeletal dysplasia, the causative mutation must be identified before prenatal testing is possible. Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements. </p>
            </list-item>
            <list-item>
              <p><bold>Fetal ultrasound examination.</bold> If the causative mutation for the other disorder present in the couple is not known or if the mutation causing hypochondroplasia cannot be identified, ultrasound examination is the only method of prenatal testing. It is often possible to detect an affected fetus early in the pregnancy if the fetus is at risk of being a compound heterozygote with another dominantly inherited skeletal dysplasia. However, it is currently difficult to detect heterozygous hypochondroplasia or other milder phenotypes using ultrasonography. Signs of disproportionate growth may suggest the diagnosis of hypochondroplasia, but a "normal" third trimester ultrasound examination is not sufficient to rule out a diagnosis of hypochondroplasia. The phenotype of homozygous hypochondroplasia has not yet been described; therefore, no statement can be made regarding prenatal diagnosis of homozygous hypochondroplasia by ultrasound examination. If significant macrocephaly is noted, it is appropriate to consider delivery by caesarean section to reduce the risk of potential CNS complications associated with a vaginal delivery.</p>
            </list-item>
          </list>
          <p>Requests for prenatal testing for conditions such as heterozygous hypochondroplasia are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing to be the choice of the parents, careful discussion of these issues is appropriate.</p>
          <p><bold>Low-risk pregnancy.</bold> A fetus with <italic toggle="yes">de novo FGFR3</italic> mutation causing hypochondroplasia who exhibits short limbs may be detected by routine ultrasound examination late in pregnancy [<xref ref-type="bibr" rid="hypochondroplasia.REF.jones.1990.404">Jones et al 1990</xref>]. DNA-based diagnosis (i.e., <italic toggle="yes">FGFR3</italic> p.Asn540Lys and p.Gly380Arg mutation analysis) via amniocentesis may be helpful in ruling out lethal forms of skeletal dysplasia and establishing a more favorable prognosis for the fetus. </p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the disease-causing mutation has been identified. </p>
        </sec>
      </sec>
      <sec id="hypochondroplasia.Resources">
        <title>Resources</title>
      </sec>
      <sec id="hypochondroplasia.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The 4.3-kb cDNA has 19 exons and encodes an 806-residue protein (isoform 1). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="hypochondroplasia" object-id="hypochondroplasia.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> A recurrent pathogenic variant (c.1620C&#x0003e;A, p.Asn540Lys) in exon 13 that encodes the ATP-binding segment of the tyrosine kinase domain was found in eight of 14 individuals with hypochondroplasia and reported first by <xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1995.357">Bellus et al [1995]</xref>. Subsequently, another mutation at the same nucleotide resulting in the same amino acid substitution (c.1620C&#x0003e;G, p.Asn540Lys) was reported [<xref ref-type="bibr" rid="hypochondroplasia.REF.prinos.1995.2097">Prinos et al 1995</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1996.182">Bellus et al 1996</xref>]. These two pathogenic variants account for the majority of over 200 reported cases of hypochondroplasia [<xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1995.357">Bellus et al 1995</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.prinos.1995.2097">Prinos et al 1995</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bellus.1996.182">Bellus et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.bonaventur.1996.33">Bonaventure et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.fofanova.1998.791">Fofanova et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.matsui.1998.1052">Matsui et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.prinster.1998.109">Prinster et al 1998</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.ramaswami.1998.99">Ramaswami et al 1998</xref>]. Several other <italic toggle="yes">FGFR3</italic> mutations have been proposed as the cause of a small number of cases of hypochondroplasia. (For more information, see <related-object source-id="gene" document-id="hypochondroplasia" object-id="hypochondroplasia.molgen.TA">Table A</related-object>.)</p>
        <table-wrap id="hypochondroplasia.T.fgfr3_pathogenic_var" position="anchor" orientation="portrait">
          <label>Table 2.</label>
          <caption>
            <p><italic toggle="yes">FGFR3</italic> Pathogenic Variants that Cause Hypochondroplasia Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table>
            <tbody>
              <tr>
                <th id="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                <th id="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.829A&#x0003e;G</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Tyr278Cys</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1612A&#x0003e;G</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Ile538Val</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_3" align="left" valign="middle" rowspan="6" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_000142.4">NM_000142.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_000133.1">NP_000133.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1619A&#x0003e;C</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Asn540Thr</td>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1620C&#x0003e;A<break/>(C1659A)</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Asn540Lys</td>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1620C&#x0003e;G <break/>(C1659G)</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Asn540Lys</td>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1950G&#x0003e;T</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Lys650Asn </td>
              </tr>
              <tr>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">c.1948A&#x0003e;C</td>
                <td headers="hd_b_hypochondroplasia.T.fgfr3_pathogenic_var_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">p.Lys650Gln</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="hypochondroplasia.TF.2">
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants. </p>
            </fn>
            <fn id="hypochondroplasia.TF.2.1">
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature</p>
            </fn>
            <fn id="hypochondroplasia.TF.2.2">
              <p>1. Variant designation that does not conform to current naming conventions</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For more information see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="PDF File" xlink:href="hypochondroplasia-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <p><bold>Normal gene product.</bold> Fibroblast growth factor receptor 3 is a receptor tyrosine kinase and ia member of the fibroblast growth factor receptor family. This family comprises four related genes in mammals (<italic toggle="yes">FGFR1</italic> - <italic toggle="yes">FGFR4</italic>) with highly conserved structure. The FGFR genes are all characterized by an extracellular ligand-binding domain consisting of three immunoglobulin (Ig) subdomains, a transmembrane domain, and a split intracellular tyrosine kinase domain [<xref ref-type="bibr" rid="hypochondroplasia.REF.johnson.1993.1">Johnson &#x00026; Williams 1993</xref>]. A stretch of four to eight acidic amino acids termed the acid box (whose function is not known) is found between the first and second Ig domains. Alternative splicing of FGFR transcripts results in several distinct mRNA isoforms that may lack one or more Ig domains, the acid box, or the intracellular tyrosine kinase domain. Some isoforms have regions of alternative sequence within the extracellular Ig domains. Exons eight and nine are alternatively spliced and encode different carboxyl termini of the third Ig domain. Alternative splicing of the FGFR genes is thought to modulate the affinity of the numerous FGFs for the receptor and may control other aspects of receptor-mediated signaling. </p>
        <p><bold>Abnormal gene product.</bold> The effects of the <italic toggle="yes">FGFR3</italic> mutations on FGFR3 function have been shown to result in constitutive activation of the receptor tyrosine kinase [<xref ref-type="bibr" rid="hypochondroplasia.REF.naski.1996.233">Naski et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.webster.1996.520">Webster &#x00026; Donoghue 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.webster.1996.4081">Webster et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.thompson.1997.4169">Thompson et al 1997</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.tavormina.1999.722">Tavormina et al 1999</xref>]. It therefore seems likely that the <italic toggle="yes">FGFR3</italic> mutations found in hypochondroplasia may result in constitutive activation of the receptor tyrosine kinase, but to a lesser degree than these other mutations. Such appears to be the case in hypochondroplasia resulting from p.Lys650Asn [G Bellus, D Donoghue, M Webster, C Francomano, unpublished results]. The premise that <italic toggle="yes">FGFR3</italic> gain-of-function mutations cause skeletal dysplasia is supported by the observation that targeted disruption of <italic toggle="yes">FGFR3</italic> in mice results in enhanced growth of long bones and vertebrae, suggesting that <italic toggle="yes">FGFR3</italic> normally functions as a negative regulator of bone growth [<xref ref-type="bibr" rid="hypochondroplasia.REF.colvin.1996.390">Colvin et al 1996</xref>, <xref ref-type="bibr" rid="hypochondroplasia.REF.deng.1996.911">Deng et al 1996</xref>]. </p>
      </sec>
      <sec id="hypochondroplasia.References">
        <title>References</title>
        <sec id="hypochondroplasia.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="hypochondroplasia.Literature_Cited.reflist0">
            <ref id="hypochondroplasia.REF.alatzogl.2009.3959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alatzoglou</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brain</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torpiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Acanthosis nigricans and insulin sensitivity in patients with achondroplasia and hypochodroplasia due to FGFR3 mutations.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <year>2009</year>
                <volume>94</volume>
                <fpage>3959</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">19622626</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.angle.1998.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Angle</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersh</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christensen</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <article-title>Molecularly proven hypochondroplasia with cloverleaf skull deformity: a novel association.</article-title>
                <source>Clin Genet</source>
                <year>1998</year>
                <volume>54</volume>
                <fpage>417</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">9842995</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.appan.1990.796">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Appan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brook</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Growth and growth hormone therapy in hypochondroplasia.</article-title>
                <source>Acta Paediatr Scand</source>
                <year>1990</year>
                <volume>79</volume>
                <fpage>796</fpage>
                <lpage>803</lpage>
                <pub-id pub-id-type="pmid">2239275</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.beals.1969.728">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beals</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia. A report of five kindreds.</article-title>
                <source>J Bone Joint Surg [Am]</source>
                <year>1969</year>
                <volume>51</volume>
                <fpage>728</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">5783850</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bellus.1999.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Przylepa</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurko</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabs</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Curry</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.</article-title>
                <source>Am J Med Genet</source>
                <year>1999</year>
                <volume>85</volume>
                <fpage>53</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">10377013</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bellus.1995.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horton</surname>
                    <given-names>WA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenhaw</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecht</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.</article-title>
                <source>Nat Genet</source>
                <year>1995</year>
                <volume>10</volume>
                <fpage>357</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">7670477</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bellus.1996.182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aylsworth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia: molecular analysis of the fibroblast growth factor receptor 3 gene.</article-title>
                <source>Ann N Y Acad Sci</source>
                <year>1996</year>
                <volume>785</volume>
                <fpage>182</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8702125</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bellus.2000.1411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spector</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speiser</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garber</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bryke</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Israel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosengren</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donoghue</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.</article-title>
                <source>Am J Hum Genet</source>
                <year>2000</year>
                <volume>67</volume>
                <fpage>1411</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">11055896</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.berk.2010.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berk</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boente Mdel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montanari</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toloza</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Primc</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prado</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayliss</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pique</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrijver</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3.</article-title>
                <source>Pediatr Dermatol</source>
                <year>2010</year>
                <volume>27</volume>
                <fpage>664</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21510009</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.blomberg.2010.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blomberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeppesen</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benfeldt</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation,acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.</article-title>
                <source>Dermatology</source>
                <year>2010</year>
                <volume>220</volume>
                <fpage>297</fpage>
                <lpage>305</lpage>
                <pub-id pub-id-type="pmid">20453470</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bober.2012.2336">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bober</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinle</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackenzie</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Achondroplasia-hypochondroplasia complex and abnormal pulmonary anatomy.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>2336</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">22888019</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bonaventur.1996.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rousseau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legeai-Mallet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maroteaux</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia.</article-title>
                <source>Acta Paediatr Suppl</source>
                <year>1996</year>
                <volume>417</volume>
                <fpage>33</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9055906</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bridges.1994.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bridges</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brook</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Progress report: growth hormone in skeletal dysplasia.</article-title>
                <source>Horm Res</source>
                <year>1994</year>
                <volume>42</volume>
                <fpage>231</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">7868078</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.bridges.1991.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bridges</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brook</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Growth of children with hypochondroplasia treated with growth hormone for up to three years.</article-title>
                <source>Horm Res</source>
                <year>1991</year>
                <volume>36</volume>
                <supplement>Suppl 1</supplement>
                <fpage>56</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">1806487</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.castrofei.2008.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castro-Feij&#x000f3;o</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loidi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parajes</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ros&#x000f3;n</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabanas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barreiro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dom&#x000ed;nguez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pombo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?</article-title>
                <source>Eur J Endocrinol</source>
                <year>2008</year>
                <volume>159</volume>
                <fpage>243</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18583390</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.colvin.1996.390">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Colvin</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohne</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McEwen</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ornitz</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.</article-title>
                <source>Nat Genet</source>
                <year>1996</year>
                <volume>12</volume>
                <fpage>390</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8630492</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.deng.1996.911">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wynshaw-Boris</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leder</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Fibroblast growth factor receptor 3 is a negative regulator of bone growth.</article-title>
                <source>Cell</source>
                <year>1996</year>
                <volume>84</volume>
                <fpage>911</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">8601314</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.dorst.1969.260">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dorst</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia.</article-title>
                <source>Birth Defects IV</source>
                <year>1969</year>
                <volume>5</volume>
                <fpage>260</fpage>
                <lpage>76</lpage>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.fano.2005.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fano</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravina</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pino</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chertkoff</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barreiro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lejarraga</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>High specificity of head circumference to recognize N540K mutation in hypochondroplasia.</article-title>
                <source>Ann Hum Biol</source>
                <year>2005</year>
                <volume>32</volume>
                <fpage>782</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16418051</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.flynn.2003.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flynn</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauli</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Double heterozygosity in bone growth disorders: four new observations and review.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2003</year>
                <volume>121A</volume>
                <fpage>193</fpage>
                <lpage>208</lpage>
                <pub-id pub-id-type="pmid">12923858</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.fofanova.1998.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fofanova</surname>
                    <given-names>OV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takamura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinoshita</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meerson</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iljina</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nechvolodova</surname>
                    <given-names>OL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evgrafov</surname>
                    <given-names>OV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peterkova</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A missense mutation of C1659 in the fibroblast growth factor receptor 3 gene in Russian patients with hypochondroplasia.</article-title>
                <source>Endocr J</source>
                <year>1998</year>
                <volume>45</volume>
                <fpage>791</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10395236</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.frydman.1974.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frydman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>The genetic entity of hypochondroplasia.</article-title>
                <source>Clin Genet</source>
                <year>1974</year>
                <volume>5</volume>
                <fpage>223</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">4838890</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.glasgow.1978.868">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Glasgow</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevin</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia.</article-title>
                <source>Arch Dis Child</source>
                <year>1978</year>
                <volume>53</volume>
                <fpage>868</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">727810</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.gunthard.1995.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gunthard</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fliegel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohnacker</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutishauser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhler</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Lung hypoplasia and severe pulmonary hypertension in an infant with double heterozygosity for spondyloepiphyseal dysplasia congenita and achondroplasia.</article-title>
                <source>Clin Genet</source>
                <year>1995</year>
                <volume>48</volume>
                <fpage>35</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">7586642</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.hall.1979.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia: clinical and radiological aspects in 39 cases.</article-title>
                <source>Radiology</source>
                <year>1979</year>
                <volume>133</volume>
                <fpage>95</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">472320</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.heselson.1979.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heselson</surname>
                    <given-names>NG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremin</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>The radiographic manifestations of hypochondroplasia.</article-title>
                <source>Clin Radiol</source>
                <year>1979</year>
                <volume>30</volume>
                <fpage>79</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">421428</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.heuertz.2006.1240">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heuertz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legeai-Mallet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2006</year>
                <volume>14</volume>
                <fpage>1240</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16912704</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.huggins.1999.396">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huggins</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chun</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whelan</surname>
                    <given-names>DT</given-names>
                  </name>
                </person-group>
                <article-title>Achondroplasia-hypochondroplasia complex in a newborn infant.</article-title>
                <source>Am J Med Genet.</source>
                <year>1999</year>
                <volume>84</volume>
                <fpage>396</fpage>
                <lpage>400</lpage>
                <pub-id pub-id-type="pmid">10360392</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.hulse.2012.1">
              <mixed-citation publication-type="confproc">Hulse T, Lin J-P, Irving M. Hypochondroplasia with hippocampal dysgenesis and neonatal onset of medial temporal lobe epilepsy. Poster. Leipzig, Germany: 51<sup>st</sup> Annual Meeting of the European Society for Paediatric Endocrinology. 2012.</mixed-citation>
            </ref>
            <ref id="hypochondroplasia.REF.johnson.1993.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>LT</given-names>
                  </name>
                </person-group>
                <article-title>Structural and functional diversity in the FGF receptor multigene family.</article-title>
                <source>Adv Cancer Res</source>
                <year>1993</year>
                <volume>60</volume>
                <fpage>1</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">8417497</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.jones.1990.404">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sperrazza</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of skeletal dysplasia identified postnatally as hypochondroplasia.</article-title>
                <source>Am J Med Genet</source>
                <year>1990</year>
                <volume>36</volume>
                <fpage>404</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">2202213</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.kozlowski.1973.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia.</article-title>
                <source>Progr Pediat Radiol</source>
                <year>1973</year>
                <volume>4</volume>
                <fpage>238</fpage>
                <lpage>49</lpage>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.kozlowski.1965.379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartkowiak</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia</article-title>
                <source>Pediatr Pol.</source>
                <year>1965</year>
                <volume>40</volume>
                <fpage>379</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">14348699</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.langer.1993.772">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Langer</surname>
                    <given-names>LO</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wadsworth</surname>
                    <given-names>DT</given-names>
                  </name>
                </person-group>
                <article-title>Patient with double heterozygosity for achondroplasia and pseudoachondroplasia, with comments on these conditions and the relationship between pseudoachondroplasia and multiple epiphyseal dysplasia, Fairbank type.</article-title>
                <source>Am J Med Genet</source>
                <year>1993</year>
                <volume>47</volume>
                <fpage>772</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">8267011</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.leroy.2007.3144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuytinck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naeyaert</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                </person-group>
                <article-title>Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143A</volume>
                <fpage>3144</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18000903</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.lie.2009.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lie</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chow</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Limb lengthening in short-stature patients using monolateral and circular external fixators.</article-title>
                <source>Hong Kong Med J.</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>280</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19652235</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.linnanki.2012.3119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Linnankivi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valanne</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toiviainen-Salo</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Neuroimaging and neurological findings in patients with hypochondroplasia and FGFR3 N540K mutation.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>3119</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">23165795</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.maroteaux.1988.105">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Maroteaux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falzon</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <source>Arch Fr Pediatr</source>
                <year>1988</year>
                <volume>45</volume>
                <fpage>105</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">3389972</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.matsui.1998.1052">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsui</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yasui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsumaki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Genotype phenotype correlation in achondroplasia and hypochondroplasia.</article-title>
                <source>J Bone Joint Surg Br</source>
                <year>1998</year>
                <volume>80</volume>
                <fpage>1052</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9853502</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.mckusick.1973.11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McKusick</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorst</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <article-title>Observations suggesting allelism of the achondroplasia and hypochondroplasia genes.</article-title>
                <source>J Med Genet</source>
                <year>1973</year>
                <volume>10</volume>
                <fpage>11</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">4697848</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.meyer.2003.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menken</surname>
                    <given-names>KU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimny</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellmich</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schatz</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Pitfall in diagnosing growth hormone deficiency in a hypochondroplastic patient with a delayed puberty.</article-title>
                <source>Exp Clin Endocrinol Diabetes</source>
                <year>2003</year>
                <volume>111</volume>
                <fpage>177</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">12784193</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.moloney.1996.48">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Moloney</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slaney</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldridge</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wall</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahlin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkie</surname>
                    <given-names>AO</given-names>
                  </name>
                </person-group>
                <article-title>Exclusive paternal origin of new mutations in Apert syndrome</article-title>
                <source>Nat Genet</source>
                <year>1996</year>
                <volume>13</volume>
                <fpage>48</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">8673103</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.mortier.2000.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nuytinck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renard</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Paepe</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene.</article-title>
                <source>J Med Genet</source>
                <year>2000</year>
                <volume>37</volume>
                <fpage>220</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10777366</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.mullis.1991.265">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullis</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brickell</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brook</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients.</article-title>
                <source>Clin Endocrinol (Oxf)</source>
                <year>1991</year>
                <volume>34</volume>
                <fpage>265</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">1879059</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.naski.1996.233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Naski</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ornitz</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.</article-title>
                <source>Nat Genet</source>
                <year>1996</year>
                <volume>13</volume>
                <fpage>233</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8640234</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.newman.1975.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunbar</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia.</article-title>
                <source>J Can Assoc Radiol</source>
                <year>1975</year>
                <volume>26</volume>
                <fpage>95</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">1158967</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.oberklaid.1979.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oberklaid</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danks</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stace</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosshandler</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine.</article-title>
                <source>J Med Genet</source>
                <year>1979</year>
                <volume>16</volume>
                <fpage>140</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">458831</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.pinto.2012.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samara-Boustani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fresneau</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viaud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souberbielle</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pineau</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polak</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Efficacy and safety of growth hormone in the treatment of children with hypochondroplasia (HCH): Comparison with a historical cohort of untreated children with HCH.</article-title>
                <source>Hormone Res Paed</source>
                <year>2012</year>
                <volume>78</volume>
                <fpage>193</fpage>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.prinos.1995.2097">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prinos</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilpatrick</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsipouras</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>A common FGFR3 gene mutation in hypochondroplasia.</article-title>
                <source>Hum Mol Genet</source>
                <year>1995</year>
                <volume>4</volume>
                <fpage>2097</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">8589686</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.prinster.1998.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prinster</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrera</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Maschio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maghnie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigone</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rigon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beluffi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiumello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Comparison of clinical-radiological and molecular findings in hypochondroplasia.</article-title>
                <source>Am J Med Genet</source>
                <year>1998</year>
                <volume>75</volume>
                <fpage>109</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9450868</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.ramaswami.1998.99">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramaswami</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumsby</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hindmarsh</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brook</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <article-title>Genotype and phenotype in hypochondroplasia.</article-title>
                <source>J Pediatr</source>
                <year>1998</year>
                <volume>133</volume>
                <fpage>99</fpage>
                <lpage>102</lpage>
                <pub-id pub-id-type="pmid">9672519</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.ravenna.1913.157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ravenna</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Achondroplasie et chondrohypoplasie: contribution clinique.</article-title>
                <source>N Iconog Salpertriere</source>
                <year>1913</year>
                <volume>26</volume>
                <fpage>157</fpage>
                <lpage>84</lpage>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.ross.2003.61">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abboudi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigelioniene</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinn</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Mesomelic and rhizomelic short stature: The phenotype of combined Leri-Weill dyschondrosteosis and achondroplasia or hypochondroplasia.</article-title>
                <source>Am J Med Genet</source>
                <year>2003</year>
                <volume>116A</volume>
                <fpage>61</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12476453</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.rothenbuh.2012.849">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rothenbuhler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linglart</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piquard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bougn&#x000e8;res</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>A pilot study of discontinuous, insulin-like growth factor 1-dosing growth hormone treatment in young children with FGFR3 N540K-mutated hypochondroplasia.</article-title>
                <source>J Pediatr.</source>
                <year>2012</year>
                <volume>160</volume>
                <fpage>849</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">22137367</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.rousseau.1996.749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rousseau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legeai-Mallet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maroteaux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and genetic heterogeneity of hypochondroplasia.</article-title>
                <source>J Med Genet</source>
                <year>1996</year>
                <volume>33</volume>
                <fpage>749</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">8880574</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.scott.1976.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>CI</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <article-title>Achondroplastic and hypochondroplastic dwarfism.</article-title>
                <source>Clin Orthop Relat Res.</source>
                <year>1976</year>
                <volume>114</volume>
                <fpage>18</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">1261109</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.sommer.1987.949">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young-Wee</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frye</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Achondroplasia-hypochondroplasia complex.</article-title>
                <source>Am J Med Genet</source>
                <year>1987</year>
                <volume>26</volume>
                <fpage>949</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">3591840</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.song.2012.2456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balce</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agashe</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hong</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>YE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <article-title>New proposed clinico-radiologic and molecular criteria in hypochondroplasia: FGFR 3 gene mutations are not the only cause of hypochondroplasia.</article-title>
                <source>Am J Med Genet A</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>2456</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">22903874</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.specht.1975.249">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Specht</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daentl</surname>
                    <given-names>DL</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia.</article-title>
                <source>Clin Orthop Relat Res.</source>
                <year>1975</year>
                <volume>110</volume>
                <fpage>249</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">1098822</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.tanaka.2003.69">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsumata</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horikawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia.</article-title>
                <source>Endocr J</source>
                <year>2003</year>
                <volume>50</volume>
                <fpage>69</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">12733711</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.tavormina.1999.722">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tavormina</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bamshad</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraley</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIntosh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jabs</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasmuth</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donoghue</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.</article-title>
                <source>Am J Hum Genet</source>
                <year>1999</year>
                <volume>64</volume>
                <fpage>722</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10053006</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.thauvinrob.2003.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Monl&#x000e9;on</surname>
                    <given-names>JV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fran&#x000e7;ois</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couailler</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos-Xavier</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia and stature within normal limits: another family with an Asn540Ser mutation in the fibroblast growth factor receptor 3 gene.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2003</year>
                <volume>119A</volume>
                <fpage>81</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">12707965</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.thomeer.2002.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomeer</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Dijk</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Surgical treatment of lumbar stenosis in achondroplasia.</article-title>
                <source>J Neurosurg</source>
                <year>2002</year>
                <volume>96</volume>
                <fpage>292</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11990837</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.thompson.1997.4169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raffioni</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasmuth</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradshaw</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells.</article-title>
                <source>Mol Cell Biol</source>
                <year>1997</year>
                <volume>17</volume>
                <fpage>4169</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">9199352</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.trotter.2005.771">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Trotter</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>JG</given-names>
                  </name>
                </person-group>
                <publisher-name>American Academy of Pediatrics Committee on Genetics</publisher-name>
                <article-title>Health supervision for children with achondroplasia.</article-title>
                <source>Pediatrics.</source>
                <year>2005</year>
                <volume>116</volume>
                <fpage>771</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">16140722</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.walker.1971.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walker</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murdoch</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKusick</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langer</surname>
                    <given-names>LO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beals</surname>
                    <given-names>RK</given-names>
                  </name>
                </person-group>
                <article-title>Hypochondroplasia.</article-title>
                <source>Am J Dis Child</source>
                <year>1971</year>
                <volume>122</volume>
                <fpage>95</fpage>
                <lpage>104</lpage>
                <pub-id pub-id-type="pmid">5564166</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.webster.1996.4081">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Avis</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donoghue</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II.</article-title>
                <source>Mol Cell Biol</source>
                <year>1996</year>
                <volume>16</volume>
                <fpage>4081</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8754806</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.webster.1996.520">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donoghue</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <article-title>Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.</article-title>
                <source>EMBO J</source>
                <year>1996</year>
                <volume>15</volume>
                <fpage>520</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8599935</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.wilkin.1998.711">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilkin</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szabo</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mack</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loughlin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Francomano</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome.</article-title>
                <source>Am J Hum Genet</source>
                <year>1998</year>
                <volume>63</volume>
                <fpage>711</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9718331</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.wynnedavi.1991.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wynne-Davies</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>The frequency of mental retardation in hypochondroplasia.</article-title>
                <source>J Med Genet</source>
                <year>1991</year>
                <volume>28</volume>
                <fpage>644</fpage>
                <pub-id pub-id-type="pmid">1956068</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.wynnedavi.1981.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wynne-Davies</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gormley</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Achondroplasia and hypochondroplasia. Clinical variation and spinal stenosis.</article-title>
                <source>J Bone Joint Surg Br.</source>
                <year>1981</year>
                <volume>63B</volume>
                <fpage>508</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">7298674</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.yasui.1997.298">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yasui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kojimoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimomura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochi</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Lengthening of the lower limbs in patients with achondroplasia and hypochondroplasia.</article-title>
                <source>Clin Orthop Relat Res.</source>
                <year>1997</year>
                <volume>344</volume>
                <fpage>298</fpage>
                <lpage>306</lpage>
                <pub-id pub-id-type="pmid">9372781</pub-id>
              </element-citation>
            </ref>
            <ref id="hypochondroplasia.REF.young.1992.831">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>ID</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruggins</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somers</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuccollo</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rutter</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Lethal skeletal dysplasia owing to double heterozygosity for achondroplasia and spondyloepiphyseal dysplasia congenita.</article-title>
                <source>J Med Genet</source>
                <year>1992</year>
                <volume>29</volume>
                <fpage>831</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">1453438</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="hypochondroplasia.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="hypochondroplasia.Author_History">
          <title>Author History</title>
          <p>Arthur S Aylsworth, MD, FACMG; University of North Carolina (1999-2005) Gary A Bellus, MD, PhD (1999-2005; 2013-present) Michael B Bober, MD, PhD (2013-present)Clair A Francomano, MD; National Institutes of Health (2005-2013) Thaddeus E Kelly, MD, PhD; University of Virginia Hospital (1999-2005) Sarah M Nikkel, MD (2013-present)George E Tiller, MD, PhD (2013-present)</p>
        </sec>
        <sec id="hypochondroplasia.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>26 September 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 December 2005 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>13 February 2003 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>15 July 1999 (pb) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>27 April 1999 (gb) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
